At a glance
ClinicalIndex Comparison RecordN/ACompleted· 32 enrolled
Drug / intervention
Profound Matrixdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Retrospective Review Evaluating the Matrix Pro Applicator for Treatment of Wrinkles
In Brief
An observational study evaluating Profound Matrix for Wrinkle. Completed, enrolled 32 participants across 2 sites in 2 countries.
Detailed Summary
This is a retrospective chart review of data from the multi-site prospective clinical trial, "Functional Usability and Feasibility Testing of the Profound Matrix™ System (FUFT2002)" to evaluate the safety and efficacy of the Profound Matrix System Matrix Pro applicator for the treatment of wrinkles.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsWrinkle
CountriesIsrael, United States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartOct 2023
Primary CompletionDec 2023
First PostedJan 2024
Study CompletionJul 2024
TodayJul 2026
First PostedJan 23, 2024
Enrollment StartOct 29, 2023
Primary CompletionDec 29, 2023
Study CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.4 years ago
Interventions
Profound Matrixdevice
The source study consisted of up to three treatment visits with treatment intervals 6 weeks ± 2 weeks